HER2+ Combo Shows Promise in Breast Cancer Brain Mets ...Middle East

Medscape - News
In previously treated patients with locally advanced unresectable or metastatic HER2-positive breast cancer, tucatinib and trastuzumab emtansine improved progression-free survival vs T-DM1 alone. MDedge News

Hence then, the article about her2 combo shows promise in breast cancer brain mets was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( HER2+ Combo Shows Promise in Breast Cancer Brain Mets )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News